| Business Summary | | Bioprogress
Technology
International,
Inc.
is
a
development
stage
company
engaged
in
the
research,
development,
manufacturing,
marketing,
sales
and
distribution
of
products
that
use
water
soluble
and
biodegradable
films
for
the
dietary
supplement,
pharmaceutical,
recreational
and
cosmetic
industries
and
other
applications,
as
well
as
flushable
and
biodegradable
products
for
the
medical
and
hygiene
industries.
Bioprogress
operates
through
three
wholly
owned
subsidiaries,
Bioprogress
Technology,
Inc.,
Bioprogress
Technology
Limited
(UK)
and
DHA
Nutrition
Limited
(UK),
and
one
partially
owned
subsidiary,
The
Healthy
Forum
Ltd.
The
Company's
primary
focus
is
on
the
development
and
commercialization
of
its
proprietary
process,
the
XGel
Film
System
(FS).
The
XGel
FS
is
used
to
produce
soft
capsules
that
are
free
from
gelatin
and
other
animal
by-products. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | BPRG
is
engaged
in
the
development,
manufacture,
sale
and
distribution
of
materials
and
processes
used
to
replace
gelatin
in
the
manufacture
of
soft
capsules,
with
particular
emphasis
on
ingestible
products.
For
the
six
months
ended
6/30/01,
revenues
totaled
$653
thousand,
up
from
$236
thousand.
Net
loss
applicable
to
Common
rose
5%
to
$4.2
million.
Results
reflect
income
from
an
evaluation
agreement
and
a
product
development
agreement,
offset
by
higher
R
and
D
expenses. | More
from
Market Guide: Significant
Developments |
| | |
| Position | Barry Muncaster, 54 | Chairman
of Directors and CEO | James Longley, 40 | CFO,
Chief Accounting Officer, Sec., Treasurer, Director | Gregg Bowers, 48 | Director;
Pres of Bioprogress Technology. | Robert Hind, 50 | VP
of Sales and Marketing | Malcolm Brown, 41 | CTO,
Director |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|